[An efficacy study of a new antispasmodica, SA-504 upon the myogram and intraluminal pressure of the human colon (author's transl)].
D000328:Adult; D003106:Colon / Q000187:drug effects* / Q000503:physiopathology; D003109:Colonic Diseases, Functional / Q000503:physiopathology; D004566:Electrodes; D004576:Electromyography; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011312:Pressure; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology; D013876:Thiophenes / Q000494:pharmacology*
D010276:Parasympatholytics; D010880:Piperidines; D013876:Thiophenes; D012633:Secretin; D009388:Neostigmine